Home » Topics » Endocrine/metabolic, BioWorld Science

Endocrine/metabolic, BioWorld Science
RSS

Tokyo Tanabe developing oxytocin antagonist

July 2, 1997

Abbott and Metabolex enter diabetes collaboration

July 1, 1997

New hypoglycemic/insulin-sensitizing agent from Novartis

July 1, 1997

Phytopharm to develop naturally occurring antiobesity agent

June 30, 1997

Anika and Orquest sign manufacturing agreement

June 30, 1997

GelTex bile acid sequestrant not absorbed from GI tract in animals

June 30, 1997

Novel progestins/antiprogestins disclosed by Ortho

June 30, 1997

Baxter's DCLHb safe in acute ischemic stroke patients

June 27, 1997

Phase II results with Immunex's Flt3 ligand reported

June 27, 1997

Kyowa Hakko discloses new calcitonin derivatives

June 27, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 5, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...